BACKGROUND: Human immunodeficiency virus (HIV) observational cohorts, which are established worldwide, support comparative studies across different regions. They have played an important role in developing international and country-specific HIV treatment and care guidelines. We describe the YRG CARE Chennai HIV observation database (YCHOD) and highlight its utility in monitoring trends in antiretroviral treatment use and HIV disease outcomes in India. METHODS: The baseline characteristics, time trends in antiretroviral treatment, trends in incidence of acquired immune deficiency syndrome (AIDS)-defining illness and mortality following the introduction of highly active antiretroviral therapy (HAART) in India were assessed using YCHOD. RESULTS: Till January 2005, 7647 HIV-positive patients had registered in YCHOD. A majority of the patients were men (69%) and had a mean age of 32 years. At baseline, 14% had an existing AIDS-defining illness. Among patients who required therapy by the WHO criteria, 14% initiated antiretroviral therapy (ART) in 1996 and 35% in 2000. Since the dramatic cost reduction of generic HAART in 2001, there has been an increase in the proportion of patients receiving ART to 57% in 2004. In patients who were started on HAART, the incidence of at least one AIDS-defining illness was 2% in 2001, and this decreased to 0.48% in 2004. CONCLUSION: We feel observational cohorts are useful as a surveillance tool for monitoring trends in treatment and disease progression. Standardized observational data collected systematically on HIV-infected individuals will help to assess the cost-effectiveness of ART and in planning ART strategies for India.
BACKGROUND:Human immunodeficiency virus (HIV) observational cohorts, which are established worldwide, support comparative studies across different regions. They have played an important role in developing international and country-specific HIV treatment and care guidelines. We describe the YRG CARE Chennai HIV observation database (YCHOD) and highlight its utility in monitoring trends in antiretroviral treatment use and HIV disease outcomes in India. METHODS: The baseline characteristics, time trends in antiretroviral treatment, trends in incidence of acquired immune deficiency syndrome (AIDS)-defining illness and mortality following the introduction of highly active antiretroviral therapy (HAART) in India were assessed using YCHOD. RESULTS: Till January 2005, 7647 HIV-positive patients had registered in YCHOD. A majority of the patients were men (69%) and had a mean age of 32 years. At baseline, 14% had an existing AIDS-defining illness. Among patients who required therapy by the WHO criteria, 14% initiated antiretroviral therapy (ART) in 1996 and 35% in 2000. Since the dramatic cost reduction of generic HAART in 2001, there has been an increase in the proportion of patients receiving ART to 57% in 2004. In patients who were started on HAART, the incidence of at least one AIDS-defining illness was 2% in 2001, and this decreased to 0.48% in 2004. CONCLUSION: We feel observational cohorts are useful as a surveillance tool for monitoring trends in treatment and disease progression. Standardized observational data collected systematically on HIV-infected individuals will help to assess the cost-effectiveness of ART and in planning ART strategies for India.
Authors: Kartik K Venkatesh; A K Srikrishnan; Kenneth H Mayer; N Kumarasamy; Sudha Raminani; E Thamburaj; Lakshmi Prasad; Elizabeth W Triche; Suniti Solomon; Steven A Safren Journal: AIDS Patient Care STDS Date: 2010-11-22 Impact factor: 5.078
Authors: Rochelle P Walensky; Eric L Ross; Nagalingeswaran Kumarasamy; Robin Wood; Farzad Noubary; A David Paltiel; Yoriko M Nakamura; Sheela V Godbole; Ravindre Panchia; Ian Sanne; Milton C Weinstein; Elena Losina; Kenneth H Mayer; Ying Q Chen; Lei Wang; Marybeth McCauley; Theresa Gamble; George R Seage; Myron S Cohen; Kenneth A Freedberg Journal: N Engl J Med Date: 2013-10-31 Impact factor: 91.245
Authors: Kartik K Venkatesh; A K Srikrishnan; Steven A Safren; Elizabeth W Triche; E Thamburaj; Lakshmi Prasad; Mark N Lurie; M Suresh Kumar; N Kumarasamy; Suniti Solomon; Kenneth H Mayer Journal: AIDS Care Date: 2011-06
Authors: K K Venkatesh; S Saghayam; B Devaleenal; S Poongulali; T P Flanigan; K H Mayer; N Kumarasamy Journal: Indian J Cancer Date: 2012 Jan-Mar Impact factor: 1.224
Authors: Anne Marie Belz Chomat; Ira B Wilson; Christine A Wanke; A Selvakumar; K R John; Rita Isaac Journal: AIDS Patient Care STDS Date: 2009-06 Impact factor: 5.078
Authors: Kenneth A Freedberg; Nagalingeswaran Kumarasamy; Elena Losina; Anitha J Cecelia; Callie A Scott; Nomita Divi; Timothy P Flanigan; Zhigang Lu; Milton C Weinstein; Bingxia Wang; Aylur K Ganesh; Melissa A Bender; Kenneth H Mayer; Rochelle P Walensky Journal: AIDS Date: 2007-07 Impact factor: 4.177
Authors: R Subbaraman; B Devaleenal; P Selvamuthu; T Yepthomi; S S Solomon; K H Mayer; N Kumarasamy Journal: Int J STD AIDS Date: 2009-07 Impact factor: 1.359
Authors: Kartik K Venkatesh; Jessica E Becker; Nagalingeswaran Kumarasamy; Yoriko M Nakamura; Kenneth H Mayer; Elena Losina; Soumya Swaminathan; Timothy P Flanigan; Rochelle P Walensky; Kenneth A Freedberg Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240